Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy (Q42950227)

11 November 2017

title

Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy (English)

1 reference

11 November 2017

1 reference

5

1 reference

11 November 2017

7

Volker Straub

1 reference

11 November 2017

Ralf Bauer

1

1 reference

11 November 2017

Alison Blain

2

1 reference

11 November 2017

Elizabeth Greally

3

1 reference

11 November 2017

Kate Bushby

4

1 reference

11 November 2017

Steve Laval

6

1 reference

11 November 2017

Guy A MacGowan

8

1 reference

11 November 2017

publication date

30 July 2010

1 reference

European Journal of Heart Failure

11 November 2017

published in

1 reference

11 November 2017

volume

12

1 reference

11 November 2017

issue

11

1 reference

11 November 2017

page(s)

1163-1170

1 reference

Cardiomyopathy in muscular dystrophies

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

The heart in human dystrophinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Serial alterations of beta-adrenergic signaling in dilated cardiomyopathic hamsters: possible role of myocardial oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycan-deficient mouse model for dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Attenuation of adverse cardiac effects in prednisolone-treated delta-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Carvedilol for children and adolescents with heart failure: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Ca2+ transient decline and myocardial relaxation are slowed during low flow ischemia in rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Pressure-calcium relationships in perfused mouse hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Evaluation of NT-proBNP to predict outcomes in advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

Evaluation of cardiac and respiratory involvement in sarcoglycanopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ129

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ129

1 reference

11 November 2017

1 reference